This Blog, by Gerbsman Partners, was launched in 2007 to establish a dialog with the equity and debt markets and sources of Technology, Life Science and Medical Device Intellectual Property. In addition, the Blog looks at new technologies, market trends, business and restructuring issues and discusses strategies for Maximizing Enterprise Value for Technology, Life Science and Medical Device companies and their Intellectual Property.
The Blog of Intellectual Capital also covers the latest Web 2.0/3.0 and Wireless 2.0 trends, products and companies and focuses on new and existing technology and economic breakthroughs
Steven R. Gerbsman, Robert Tillman, Ronald Coelyn, Tony Fish, Patric Carlsson, Hans Ullmark, Andrew Sherman and other members of Gerbsman Partners Board of Intellectual Capital, all contribute on a regular basis, providing their perspective, analysis and opinions of current market conditions.
Gerbsman Partners formed its “Board of Intellectual Capital” as a resource for rapidly identifying business and marketing strategies, strategic alliance candidates and financing for highly leveraged, under-performing, under-capitalized and under-valued Technology, Life Science, Wireless, Medical Device and low tech companies and their Intellectual Property.
This distinguished group includes nationally and internationally recognized financial, communications, media, advertising, public relations, technology and operating executives.
About Gerbsman Partners
Gerbsman Partners is a Crisis Management/Private Investment Banking firm that is strategically positioned to assist portfolio companies of equity investors, senior lenders and bondholders to maximize enterprise value. Gerbsman Partners also assists Universities, Corporations and Equity sponsors maximize value of their Intellectual Property. Gerbsman Partners leverages its domain expertise and extensive experience to the benefit of all stakeholders at interest, both nationally and internationally through our Board of Intellectual Capital.
Since inception in 1980, Gerbsman Partners has been involved in over $ 2.3 billion of restructurings, M&A and financing transactions. Since 2001, Gerbsman Partners has been involved in maximizing enterprise and intellectual property value for 62 venture/private equity backed and/or senior lender financed, technology, life science and medical device companies through its proprietary “Date Certain M&A Process”. Gerbsman Partners has also terminated/restructured over $795 million of prohibitive real estate and equipment leases, as well as sub-debt and creditor issues and has also assisted Web 2.0/3.0 and Mobile 2.0 companies with strategic alliance development, M&A activities, licensing and distribution of content in the US, Europe and Israel.
Gerbsman Partners has offices and strategic alliances and offices in San Francisco, New York, Boston, Alexandria/Washington DC, Europe and Israel
For more information, please visit Gerbsman Partners website
